BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2842989)

  • 1. [A trial of rabies vaccine treatment of patients with glioblastoma multiforme].
    Filipov FV
    Zh Vopr Neirokhir Im N N Burdenko; 1988; (3):38-40. PubMed ID: 2842989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of glioblastoma multiforme: a new standard.
    Henson JW
    Arch Neurol; 2006 Mar; 63(3):337-41. PubMed ID: 16533960
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy.
    Patwardhan RV; Shorter C; Willis BK; Reddy P; Smith D; Caldito GC; Nanda A
    Surg Neurol; 2004 Sep; 62(3):207-13; discussion 214-5. PubMed ID: 15336860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of glioma patients after complementary treatment with galactoside-specific lectin from mistletoe.
    Lenartz D; Dott U; Menzel J; Schierholz JM; Beuth J
    Anticancer Res; 2000; 20(3B):2073-6. PubMed ID: 10928154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccine for aggressive brain tumors may prolong survival.
    Health News; 2004 Dec; 10(12):7. PubMed ID: 15645564
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of treatment for glioblastoma multiforme in elderly patients (65+): a retrospective analysis.
    Kushnir I; Tzuk-Shina T
    Isr Med Assoc J; 2011 May; 13(5):290-4. PubMed ID: 21845970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Surgical treatment and radiation therapy for glioblastoma multiforme, with special reference to intraoperative radiotherapy].
    Matsutani M; Matsuda T; Nagashima T; Kohno T; Hoshino T; Terao H
    Gan No Rinsho; 1984 Apr; 30(4):325-33. PubMed ID: 6328061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the treatment and survival rates of 138 patients with glioblastoma multiforme.
    Jubelirer SJ
    W V Med J; 1996; 92(4):186-90. PubMed ID: 8772403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An example of how patient selection can influence survival in glioblastoma multiforme.
    Gilbert HA; Cassidy F; Wagner J; Eder D; Kagan AR; Cove JK
    Cancer Clin Trials; 1978; 1(2):103-5. PubMed ID: 229979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioblastoma multiforme: evidence-based approach to therapy.
    Nicholas MK
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S23-7. PubMed ID: 18076314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of extent of tumor resection on the outcome of combined therapy in patients with glioblastoma multiforme].
    Jeremić B; Grulicić D; Samardzić M; Antunović V; Joksimović M; Djurić Lj; Milicić B; Nikolić N
    Srp Arh Celok Lek; 1997; 125(3-4):93-8. PubMed ID: 9221525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients.
    Wheeler CJ; Black KL; Liu G; Mazer M; Zhang XX; Pepkowitz S; Goldfinger D; Ng H; Irvin D; Yu JS
    Cancer Res; 2008 Jul; 68(14):5955-64. PubMed ID: 18632651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma multiforme.
    Conrad FG; Myers P; Buckley R
    Minn Med; 1969 Mar; 52(3):491-7. PubMed ID: 4307026
    [No Abstract]   [Full Text] [Related]  

  • 15. [Adoptive immunotherapy in glioblastoma multiforme: experience with the use of intrathecal infusions of autologous leukocytes].
    Vaquero J; Martínez R; de Haro J; Barbolla L; Salazar J; Santos H
    Arch Neurobiol (Madr); 1987; 50(3):183-90. PubMed ID: 3039937
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined treatment of glyal and metastatic tumors of the brain].
    Fadeev BP; Zhabina RM
    Vestn Khir Im I I Grek; 2005; 164(1):80-2. PubMed ID: 15957817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Adjuvant immunotherapy with levamisole for malignant glioma].
    Takakura K; Shitara N; Kohno T
    No To Shinkei; 1983 Mar; 35(3):299-303. PubMed ID: 6305380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with reoperation on recurrent glioblastoma multiforme.
    Pinsker M; Lumenta C
    Zentralbl Neurochir; 2001; 62(2):43-7. PubMed ID: 11786935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cure following gene therapy for recurrent glioblastoma multiforme?
    Karabatsou K; Bernstein M
    Acta Neurochir (Wien); 2008 Jun; 150(6):611-2. PubMed ID: 18511998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.